Clinical Publications and Awards | GT Medical Technologies

Should Brachytherapy Play A Key Role in the Treatment of Adult Malignant Brain Tumors?

Opinion Piece:
Yes. Brachytherapy for the treatment of intracranial malignancies holds tremendous promise for optimal management of these frequently complex patients. – Drs. Weinberg and Beckham
No. The role of brachytherapy for malignant gliomas has been well investigated and found to confer no survival benefit for patients when combined with best surgical resection and standard external radiotherapy. – Dr. Barnett

CS-131 for Operable Intracranial Neoplasms

Dr. Kotecha: Radiation therapy can be delivered to the brain externally through machines, which is called external beam radiation therapy. This is the most common approach or use in radiation therapy and some terms that you may hear that are using this type of treatment are stereotactic radiosurgery. An alternative means of delivering radiation therapy is when radiation is actually implanted into the brain itself, and that is called brachytherapy.

GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas

Neuro-Oncology Advances 2021 | Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas [published online December 27, 2021]. https://doi.org/10.1093/noajnl/vdab185

A Call for Patients to Resume Routine Cancer Screenings and Treatment

During these uncertain times, remember to proactively reach out to patients and encourage them to resume routine cancer screenings to prevent delayed diagnoses that might lead to worsened health outcomes.

Safety and Efficacy of GammaTile Intracranial Brachytherapy Implanted During Awake Craniotomy

Brachytherapy 2021 | Shearwood McClelland, Ulysses G Gardner, Yi Le, Sook Kien Ng, Mitesh V Shah, Gordon A Watson. Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy [published online September 26, 2021]. Brachytherapy. doi.org/10.1016/j.brachy.2021.08.011.

First Clinical Implementation of GammaTile Permanent Brain Implants After FDA Clearance

Brachytherapy 2021 | Ferreira C, Sterling C, Reynolds M, Dusenbery K, Chen C, Alaei A. First clinical implementation of GammaTile permanent brain implants after FDA clearance [published online ahead of print January 21,2021]. Brachytherapy. doi: 10.1016/j.brachy.2020.12.005.

Surgical Outcomes of a Novel Collagen Tile Cesium Brachytherapy for Intracranial Malignancy at a Tertiary Referral Center

2020 Georgia Neurosurgical Society Annual Fall Meeting | Andrew B. Boucher, MD; Hui-Kuo Shu MD, PhD; Jeffrey J. Olson, MD; Kimberly B. Hoang, MD. Emory University. Presented at 2020 Georgia Neurosurgical Society Annual Fall Meeting.

A Prospective Trial of Resection and Surgically Targeted Radiation Therapy for Initial or Salvage Treatment of Aggressive Meningioma

SNO Annual Meeting 2020 | L. Rogers, P. Nakaji, E. Youssef, K. Smith, J. Zabramski, T. Thomas, C. Dardis, D. Pinnaduwage and D. Brachman; St Joseph’s Hospital, Phoenix, AZ, Barrow Neurological Institute, Phoenix, AZ, GT Medical Technologies, Tempe, AZ.

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial

Cureus 2020 | Peter Nakaji, Kris Smith, Emad Youssef, Theresa Thomas, Dilini Pinnaduwage, Leland Rogers, Garrick Wallstrom, David Brachman. Cureus. 2020;12(11):e11570.

Resection and Surgically Targeted Radiation Therapy for Initial or Salvage Treatment of Aggressive Meningioma: Results From a Prospective Trial

Clinical Neurosurgery | Leland Rogers, MD; Peter Nakaji, MD; Emad Youssef, MD; Kris A. Smith, MD; Joseph Zabramski, MD; Theresa Thomas, MS; Christopher Dardis, MD; Dilini Pinnaduwage, PhD; David G. Brachman, MD; St Joseph’s Hospital, Phoenix, AZ; Barrow Neurological Institute, Phoenix, AZ; GT Medical Technologies, Tempe, AZ.

Content Type: Clinical Publications and Awards